Molecular Reference

News, approvals & upcoming readouts

What has actually happened, and what's coming, in peptide research — built from real trial records and FDA data, not press releases. The timeline below logs recent clinical milestones; the forward calendar lists trials whose primary results are due, so you can see which readouts to watch.

Data as of October 11, 2026 ·40 upcoming readouts · 19 FDA-approved compounds

Upcoming trial readouts

These studies have a primary-completion date in the future — the point at which their main results are expected. It's the closest thing to a real "what's next" calendar for peptides, and it's built straight from ClinicalTrials.gov, so it grows and shifts as sponsors update their timelines.

  1. L-Tyrosine — Trial scheduled to start (Phase 2)

    NCT07796373 · National Heart, Lung, and Blood Institute (NHLBI) · Not yet recruiting

  2. L-Carnitine / ALCAR — Trial scheduled to start (Phase 4)

    NCT07862725 · Hamad Medical Corporation · Not yet recruiting

  3. L-Leucine — Trial scheduled to start (Phase 2)

    NCT07647003 · NuSirt Biopharma · Not yet recruiting

  4. Semaglutide — Trial scheduled to start (Phase 4)

    NCT06977438 · University of Minnesota · Not yet recruiting

  5. Alanine — Trial scheduled to start (Phase 2)

    NCT06954987 · National Cancer Institute (NCI) · Not yet recruiting

  6. Creatine — Primary completion expected (N/A)

    NCT07838805 · University of Padova · Not yet recruiting

  7. Survodutide — Trial scheduled to start (Phase 3)

    NCT07850063 · Boehringer Ingelheim · Not yet recruiting

  8. L-Threonine — Primary completion expected (Phase 2)

    NCT06008093 · AstraZeneca · Active, not recruiting

  9. 5-HTP — Primary completion expected (N/A)

    NCT06718452 · University of Campania Luigi Vanvitelli · Not yet recruiting

  10. Setmelanotide — Primary completion expected (Phase 2)

    NCT06772597 · Rhythm Pharmaceuticals, Inc. · Active, not recruiting

  11. Survodutide — Trial scheduled to start (Phase 3)

    NCT07850050 · Boehringer Ingelheim · Not yet recruiting

  12. L-Carnitine / ALCAR — Trial scheduled to start (Phase 2)

    NCT07216001 · Claudia R. Morris · Not yet recruiting

  13. Defensins — Primary completion expected (N/A)

    NCT03704766 · Hospital for Special Surgery, New York · Recruiting

  14. Dulaglutide — Trial scheduled to start (Phase 4)

    NCT07027969 · Ali Aminian · Not yet recruiting

  15. GABA — Trial scheduled to start (Phase 4)

    NCT07732452 · McGill University Health Centre/Research Institute of the McGill University Health Centre · Not yet recruiting

  16. L-Citrulline — Primary completion expected (Phase 4)

    NCT07642505 · Beni-Suef University · Recruiting

  17. L-Citrulline — Trial scheduled to start (Phase 2)

    NCT07672782 · GOG Foundation · Not yet recruiting

  18. Liraglutide — Trial scheduled to start (Phase 4)

    NCT07027969 · Ali Aminian · Not yet recruiting

  19. Mazdutide — Trial scheduled to start (Phase 2)

    NCT07781150 · Tongji Hospital · Not yet recruiting

  20. NAD+ — Trial scheduled to start (Phase 4)

    NCT07832084 · Jing Luo · Not yet recruiting

  21. Orforglipron — Trial scheduled to start (Phase 4)

    NCT07729332 · Massachusetts General Hospital · Not yet recruiting

  22. L-Phenylalanine — Primary completion expected (Phase 2)

    NCT04018937 · Emory University · Active, not recruiting

  23. Retatrutide — Primary completion expected (Phase 3)

    NCT06662383 · Eli Lilly and Company · Active, not recruiting

  24. Semaglutide — Trial scheduled to start (Phase 4)

    NCT07832084 · Jing Luo · Not yet recruiting

  25. Tirzepatide — Trial scheduled to start (Phase 4)

    NCT07832084 · Jing Luo · Not yet recruiting

  26. L-Tyrosine — Primary completion expected (Phase 2)

    NCT03796884 · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · Active, not recruiting

  27. Semaglutide — Trial scheduled to start (Phase 3)

    NCT07866066 · Amgen · Not yet recruiting

  28. Alanine — Trial scheduled to start (Phase 2)

    NCT07582172 · City of Hope Medical Center · Recruiting

  29. Beta-alanine — Trial scheduled to start (Phase 2)

    NCT07582172 · City of Hope Medical Center · Recruiting

  30. L-Phenylalanine — Trial scheduled to start (Phase 2)

    NCT07582172 · City of Hope Medical Center · Recruiting

  31. Semaglutide — Trial scheduled to start (Phase 3)

    NCT07855900 · Boehringer Ingelheim · Not yet recruiting

  32. Survodutide — Trial scheduled to start (Phase 3)

    NCT07855900 · Boehringer Ingelheim · Not yet recruiting

  33. Tirzepatide — Trial scheduled to start (Phase 3)

    NCT07855900 · Boehringer Ingelheim · Not yet recruiting

  34. L-Serine — Primary completion expected (Phase 3)

    NCT05050084 · NRG Oncology · Active, not recruiting

  35. L-Threonine — Primary completion expected (Phase 1)

    NCT07343960 · AstraZeneca · Recruiting

  36. L-Tryptophan — Primary completion expected (Phase 3)

    NCT05050084 · NRG Oncology · Active, not recruiting

  37. Creatine — Trial scheduled to start (N/A)

    NCT07838090 · Medical University of South Carolina · Not yet recruiting

  38. Creatine — Primary completion expected (—)

    NCT06393647 · Ankara Etlik City Hospital · Recruiting

  39. Alanine — Primary completion expected (Phase 2)

    NCT05781321 · Mayo Clinic · Active, not recruiting

  40. L-DOPA (levodopa) — Primary completion expected (Phase 2)

    NCT05781321 · Mayo Clinic · Active, not recruiting

This calendar is seeded and grows. Entries are the primary-completion dates trial sponsors have registered — real, dated, and citable, but sponsors do move them, and a completion date isn't a guarantee of published results. We show only what the data supports and never add an "upcoming" event we can't trace to a registered trial.

Recent clinical milestones

A running log of trials that recently started or reached their primary-completion date — the freshest activity in the field, newest first. Each milestone is a real, dated event from a registered study.

  1. Homocysteine — Registered completion date passed (Phase 3)

    NCT07163364 · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Not yet recruiting

  2. GABA — Trial started (Phase 4)

    NCT07859839 · Post Graduate Institute of Medical Education and Research, Chandigarh · Not yet recruiting

  3. L-Arginine — Trial started (Phase 3)

    NCT07759453 · IRCCS Azienda Ospedaliero-Universitaria di Bologna · Not yet recruiting

  4. L-Arginine — Registered completion date passed (Phase 2)

    NCT06036004 · University Hospital, Basel, Switzerland · Recruiting

  5. Creatine — Trial started (N/A)

    NCT07827014 · Qualia Life Sciences · Recruiting

  6. L-Cysteine — Trial started (Phase 3)

    NCT07543458 · Oxford University Clinical Research Unit, Vietnam · Not yet recruiting

  7. Glutathione — Trial started (Phase 3)

    NCT07543458 · Oxford University Clinical Research Unit, Vietnam · Not yet recruiting

  8. Humanin — Registered completion date passed (N/A)

    NCT07678073 · University of Gaziantep · Recruiting

  9. L-Citrulline — Registered completion date passed (Phase 2)

    NCT07617909 · Beni-Suef University · Recruiting

  10. L-Theanine — Registered completion date passed (N/A)

    NCT07475299 · Iuliu Hatieganu University of Medicine and Pharmacy · Not yet recruiting

  11. Mazdutide — Trial started (Phase 2)

    NCT07843862 · Fujian Shengdi Pharmaceutical Co., Ltd. · Not yet recruiting

  12. L-Methionine — Trial started (Phase 2)

    NCT06258525 · Cedars-Sinai Medical Center · Not yet recruiting

  13. MOTS-c — Registered completion date passed (N/A)

    NCT07678073 · University of Gaziantep · Recruiting

  14. NAC (N-acetylcysteine) — Trial started (Phase 3)

    NCT07543458 · Oxford University Clinical Research Unit, Vietnam · Not yet recruiting

  15. NAD+ — Trial started (Phase 2)

    NCT07839130 · Beijing Children's Hospital · Not yet recruiting

  16. NAD+ — Registered completion date passed (—)

    NCT06866236 · Ebima Clifford Okundaye · Not yet recruiting

  17. Orforglipron — Trial started (Phase 4)

    NCT07739537 · Massachusetts General Hospital · Not yet recruiting

  18. Retatrutide — Registered completion date passed (Phase 3)

    NCT06297603 · Eli Lilly and Company · Active, not recruiting

  19. SAMe — Trial started (Phase 2)

    NCT06258525 · Cedars-Sinai Medical Center · Not yet recruiting

  20. Semaglutide — Trial started (Phase 4)

    NCT07859150 · General Committee of Teaching Hospitals and Institutes, Egypt · Not yet recruiting

  21. Semaglutide — Trial started (Phase 4)

    NCT07859163 · General Committee of Teaching Hospitals and Institutes, Egypt · Not yet recruiting

  22. Semaglutide — Trial started (Phase 4)

    NCT07859176 · General Committee of Teaching Hospitals and Institutes, Egypt · Not yet recruiting

  23. Semaglutide — Trial started (Phase 4)

    NCT07859189 · General Committee of Teaching Hospitals and Institutes, Egypt · Not yet recruiting

  24. Semaglutide — Trial started (Phase 4)

    NCT07859137 · General Committee of Teaching Hospitals and Institutes, Egypt · Not yet recruiting

  25. Taurine — Trial started (Phase 2)

    NCT07457632 · University of Alabama at Birmingham · Withdrawn

  26. Tirzepatide — Trial started (Phase 3)

    NCT07845500 · Pfizer · Not yet recruiting

  27. L-Carnitine / ALCAR — Registered completion date passed (Phase 3)

    NCT05602194 · Children's Oncology Group · Active, not recruiting

  28. Cerebrolysin — Registered completion date passed (Phase 4)

    NCT04427241 · Konkuk University Medical Center · Recruiting

  29. L-Cysteine — Trial started (Phase 3)

    NCT07737262 · Peking University People's Hospital · Not yet recruiting

  30. GABA — Trial started (Phase 4)

    NCT07288528 · McMaster University · Not yet recruiting

  31. L-Isoleucine — Registered completion date passed (N/A)

    NCT06883422 · Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran · Recruiting

  32. NAC (N-acetylcysteine) — Trial started (Phase 3)

    NCT07737262 · Peking University People's Hospital · Not yet recruiting

  33. L-Phenylalanine — Registered completion date passed (Phase 4)

    NCT07044232 · Aarhus University Hospital · Recruiting

  34. GABA — Trial started (Phase 4)

    NCT07840183 · Northwestern University · Recruiting

  35. L-Theanine — Registered completion date passed (N/A)

    NCT07682532 · Medipol University · Recruiting

  36. L-Histidine — Trial started (Phase 2)

    NCT07489430 · University of Pennsylvania · Recruiting

  37. Mazdutide — Registered completion date passed (Phase 2)

    NCT06862908 · Innovent Biologics (Suzhou) Co. Ltd. · Active, not recruiting

  38. L-Serine — Trial started (Phase 3)

    NCT07475949 · First Affiliated Hospital of Guangxi Medical University · Recruiting

  39. L-Serine — Trial started (Phase 3)

    NCT07668323 · The First Affiliated Hospital with Nanjing Medical University · Recruiting

  40. Creatine — Trial started (N/A)

    NCT07838805 · University of Padova · Not yet recruiting

FDA-approved products on record

Every compound in our database with at least one approved product in the FDA's Drugs@FDA database, with its application number and sponsor. These are the peptides (and a few small molecules) that cleared the full approval bar — a small minority of the field.

A note on dates: the openFDA feed we use gives us the approval record — the application number, sponsor, and marketed brands — but not a clean approval date for every product. Rather than print a date we can't verify, we show the verifiable record and link to the Drugs@FDA database, where the full approval history lives.

FDA-approved products by compound (Drugs@FDA).
CompoundBrand(s)ApplicationSponsorMarketing
Betaine (TMG)Betaine anhydrousANDA210508EtonPrescription
Betaine (TMG)BetaineANDA214864Novitium pharmaPrescription
Betaine (TMG)CystadaneNDA020576Recordati rarePrescription
DulaglutideTrulicityBLA125469Eli lilly and coPrescription
ExenatideExenatideANDA206697AmnealPrescription
ExenatideByettaNDA021773Astrazeneca abDiscontinued
GlutathioneBss plusNDA018469AlconPrescription
GlycinePremasol - sulfite-free (amino acid)ANDA075880Baxter hlthcarePrescription
GlycinePlenamineANDA091112B braunPrescription
GlycineGlycineNDA016784B braunPrescription
GlycineGlycineNDA017865Baxter hlthcarePrescription
GlycineGlycineNDA018315Otsuka icu medclPrescription
GlycineTravasolNDA018931Baxter hlthcarePrescription
GlycineTrophamineNDA019018B braunPrescription
GlycineAminosyn-pfNDA019398Otsuka icu medclPrescription
GlycineAminosyn-pfNDA019492Otsuka icu medclPrescription
GlycineAminosyn iiNDA020015Otsuka icu medclPrescription
GlycineAminosyn iiNDA020041Otsuka icu medclPrescription
GlycineClinimix eNDA020678Baxter hlthcarePrescription
GlycineClinimixNDA020734Baxter hlthcarePrescription
GlycineKabiven, PerikabivenNDA200656Fresenius kabi usaPrescription
L-DOPA (levodopa)Carbidopa and levodopaANDA073589Dr reddys labs saPrescription
L-DOPA (levodopa)Carbidopa and levodopaANDA073607Dr reddys labs saPrescription
L-DOPA (levodopa)Carbidopa and levodopaANDA073618Dr reddys labs saPrescription
L-DOPA (levodopa)Carbidopa and levodopaANDA075091MylanPrescription
L-DOPA (levodopa)Carbidopa and levodopaANDA076521Impax labsPrescription
L-DOPA (levodopa)Carbidopa and levodopaANDA077828Sun pharm indsDiscontinued
L-DOPA (levodopa)Carbidopa and levodopaANDA078536Sun pharm indsPrescription
L-DOPA (levodopa)Carbidopa and levodopaANDA078690Sun pharmPrescription
L-DOPA (levodopa)Carbidopa and levodopaANDA078893RisingPrescription
L-DOPA (levodopa)Carbidopa and levodopaANDA202323Accord hlthcarePrescription
L-DOPA (levodopa)Carbidopa and levodopaANDA210341AlembicPrescription
L-DOPA (levodopa)Carbidopa and levodopaANDA214091Sciegen pharmsPrescription
L-DOPA (levodopa)Carbidopa and levodopaANDA214092Sciegen pharmsPrescription
L-DOPA (levodopa)Carbidopa, levodopa and entacaponeANDA214495Macleods pharmsPrescription
L-DOPA (levodopa)Carbidopa and levodopaANDA216537Aurobindo pharma ltdPrescription
L-DOPA (levodopa)Carbidopa and levodopaANDA217482Rubicon researchPrescription
L-DOPA (levodopa)Carbidopa, levodopa and entacaponeANDA218535AlembicPrescription
L-DOPA (levodopa)Carbidopa and levodopaANDA218939Ascent pharms incPrescription
L-DOPA (levodopa)SinemetNDA017555OrganonPrescription
L-DOPA (levodopa)Carbidopa, levodopa, and entacaponeNDA021485Orion pharmaPrescription
L-DOPA (levodopa)Carbidopa and levodopa, RytaryNDA203312ImpaxPrescription
L-DOPA (levodopa)DuopaNDA203952AbbviePrescription
L-DOPA (levodopa)InbrijaNDA209184MerzPrescription
L-DOPA (levodopa)DhivyNDA214869Avion pharmsPrescription
L-DOPA (levodopa)CrexontNDA217186ImpaxPrescription
L-GlutamineL-glutamineANDA215647Novitium pharmaPrescription
L-GlutamineL-glutamineANDA219722Annora pharmaPrescription
L-GlutamineL-glutamineANDA219750Renova pharmsPrescription
L-TyrosineTrophamineNDA019018B braunPrescription
L-TyrosineAminosyn iiNDA020015Otsuka icu medclPrescription
L-TyrosineAminosyn iiNDA020041Otsuka icu medclPrescription
LiraglutideLiraglutideANDA214568Teva pharmsPrescription
LiraglutideLiraglutideANDA215245Biocon pharmaPrescription
LiraglutideLiraglutideANDA215421LupinPrescription
LiraglutideLiraglutideANDA215503HikmaPrescription
LiraglutideLiraglutideANDA217063Biocon pharmaPrescription
LiraglutideLiraglutideANDA217234OrbicularPrescription
LiraglutideLiraglutideANDA217590OrbicularPrescription
LiraglutideLiraglutideANDA218115Nanjing king friendPrescription
LiraglutideXultophy 100/3.6BLA208583NovoPrescription
LiraglutideLiraglutide, VictozaNDA022341Novo nordisk incPrescription
LiraglutideSaxendaNDA206321NovoPrescription
Melanotan I (afamelanotide)ScenesseNDA210797Clivunel incPrescription
NAC (N-acetylcysteine)AcetylcysteineANDA072489Am regentPrescription
NAC (N-acetylcysteine)AcetylcysteineANDA072547Am regentPrescription
NAC (N-acetylcysteine)AcetylcysteineANDA073664HospiraPrescription
NAC (N-acetylcysteine)AcetylcysteineANDA074037HospiraPrescription
NAC (N-acetylcysteine)AcetylcysteineANDA091684Sagent pharms incPrescription
NAC (N-acetylcysteine)AcetylcysteineANDA200644Fresenius kabi usaPrescription
NAC (N-acetylcysteine)AcetylcysteineANDA203853AlvogenPrescription
NAC (N-acetylcysteine)AcetylcysteineANDA204674AlvogenPrescription
NAC (N-acetylcysteine)AcetylcysteineANDA207358Eugia pharmaPrescription
NAC (N-acetylcysteine)AcetylcysteineANDA213693Glenmark pharmsPrescription
NAC (N-acetylcysteine)AcetylcysteineANDA214177Conba usaPrescription
NAC (N-acetylcysteine)AcetylcysteineANDA215620Regcon holdingsPrescription
NAC (N-acetylcysteine)AcetylcysteineANDA217182Onesource specialtyPrescription
NAC (N-acetylcysteine)AcetylcysteineANDA218397Somerset theraps llcPrescription
NAC (N-acetylcysteine)AcetylcysteineANDA219194Somerset theraps llcPrescription
NAC (N-acetylcysteine)Acetadote, AcetylcysteineNDA021539ApotexPrescription
OrforglipronFoundayoNDA220934Eli lilly and coPrescription
PT-141 (bremelanotide)VyleesiNDA210557CosettePrescription
SemaglutideOzempic, RybelsusNDA213051NovoPrescription
SetmelanotideImcivreeNDA213793RhythmPrescription
SS-31 (elamipretide)ForzinityNDA215244Stealth biotherapsPrescription
TaurinePremasol - sulfite-free (amino acid)ANDA075880Baxter hlthcarePrescription
TaurineTrophamineNDA019018B braunPrescription
TaurineAminosyn-pfNDA019398Otsuka icu medclPrescription
TaurineAminosyn-pfNDA019492Otsuka icu medclPrescription
TesamorelinEgrifta wr, Egrifta svBLA022505TheratechnologiesPrescription
TirzepatideMounjaro, Mounjaro kwikpenNDA215866Eli lilly and coPrescription
TirzepatideZepbound, Zepbound kwikpenNDA217806Eli lilly and coPrescription